Publications by authors named "E A De Leacy"

Background: Bronchoalveolar lavage (BAL) is essential in determining the efficacy of novel therapies in alpha-1 antitrypsin deficiency (AATD). These require initial proof-of-concept demonstration that treatment administration increases alpha-1 antitrypsin (AAT) levels and/or anti-neutrophil elastase inhibitory capacity (ANEC) in the lung. Early-phase studies often encounter high interindividual variability of BAL results, primarily stemming from the inherent dilution characteristics of returned BAL fluid.

View Article and Find Full Text PDF
Article Synopsis
  • Immunosuppressive treatment for rheumatic diseases helps maintain remission but raises infection risk and diminishes response to SARS-CoV-2 vaccination.
  • The study evaluated immune responses to SARS-CoV-2 in two patient groups: one during acute infection and one post-vaccination, comparing results among those exposed to rituximab, other immunosuppressive treatments, and non-immunosuppressed individuals.
  • Results showed that while non-immunosuppressed patients had stronger T cell responses during infection, those on immunosuppression had reduced activation, with rituximab-treated patients showing preserved T cell responses but poor antibody production post-vaccination.
View Article and Find Full Text PDF

Introduction: Immunometabolism examines the links between immune cell function and metabolism. Dysregulation of immune cell metabolism is now an established feature of innate immune cell activation. Advances in liquid chromatography mass spectrometry (LC-MS) technologies have allowed discovery of unique insights into cellular metabolomics.

View Article and Find Full Text PDF

: The current coronavirus disease 2019 (COVID-19) pandemic began in Ireland with the first confirmed positive case in March 2020. In the early stages of the pandemic clinicians and researchers in two affiliated Dublin hospitals identified the need for a COVID-19 biobanking initiative to support and enhance research into the disease. Through large scale analysis of clinical, regional, and genetic characteristics of COVID-19 patients, biobanks have helped identify, and so protect, at risk patient groups The STTAR Bioresource has been created to collect and store data and linked biological samples from patients with SARS-CoV-2 infection and healthy and disease controls.

View Article and Find Full Text PDF

Clinical and experimental data suggest that pathogenesis in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis is driven by ANCA-mediated activation of neutrophils and monocytes. While the role of neutrophils has been extensively investigated, the function of monocytes remains relatively understudied. We have previously demonstrated that stimulation of monocytes with anti-myeloperoxidase (MPO), but not anti-proteinase-3 (PR3), antibodies results in production of the pro-inflammatory cytokine IL-1β.

View Article and Find Full Text PDF